Anthony Mack
2021
In 2021, Anthony Mack earned a total compensation of $758K as Chief Executive Officer at Virpax Pharmaceuticals, a 25% increase compared to previous year.
Compensation breakdown
Bonus | $225,000 |
---|---|
Option Awards | $158,000 |
Salary | $375,000 |
Total | $758,000 |
Mack received $375K in salary, accounting for 49% of the total pay in 2021.
Mack also received $225K in bonus and $158K in option awards.
Rankings
In 2021, Anthony Mack's compensation ranked 9,653rd out of 12,415 executives tracked by ExecPay. In other words, Mack earned more than 22.2% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 9,653 out of 12,415 | 22nd |
Division Manufacturing | 4,276 out of 5,508 | 22nd |
Major group Chemicals And Allied Products | 1,893 out of 2,378 | 20th |
Industry group Drugs | 1,679 out of 2,099 | 20th |
Industry Pharmaceutical Preparations | 1,249 out of 1,549 | 19th |
Source: SEC filing on June 15, 2022.
Mack's colleagues
We found two more compensation records of executives who worked with Anthony Mack at Virpax Pharmaceuticals in 2021.